The aim of this study was to establish whether NT-proBNP levels in postmenopausal women with type 2 diabetes remain within narrow biological limits or vary more widely over time when compared with a matched control group of postmenopausal women without diabetes. The gene discussed is NPPB; the disease is type 2 diabetes mellitus.